[Protracted chemical burns (with special reference to skin damages caused by epoxides and propansultone)].
D000062:Accidents, Occupational; D000109:Acetylcholine / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001414:Bacitracin / Q000009:adverse effects; D002057:Burns, Chemical / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D002254:Carbonates / Q000627:therapeutic use; D002617:Chemical Industry; D002712:Chlorides / Q000627:therapeutic use; D004952:Esters / Q000009:adverse effects; D004988:Ethers, Cyclic / Q000009:adverse effects*; D005076:Exanthema / Q000139:chemically induced; D006496:Heparinoids / Q000627:therapeutic use; D006571:Heterocyclic Compounds / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009355:Neomycin / Q000009:adverse effects; D009784:Occupational Diseases / Q000139:chemically induced*; D010406:Penicillins / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000009:adverse effects*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000891:Anti-Infective Agents, Local; D002254:Carbonates; D002712:Chlorides; D004952:Esters; D004988:Ethers, Cyclic; D006496:Heparinoids; D006571:Heterocyclic Compounds; D010406:Penicillins; D011725:Pyridines; D013451:Sulfonic Acids; D014665:Vasodilator Agents; D001414:Bacitracin; D012965:Sodium Chloride; D012964:Sodium; D009355:Neomycin; D011729:Pyridostigmine Bromide; D000109:Acetylcholine
Die "protrahierte Verätzung" (unter besonderer Berücksichtigung der Hautschäden durch Epoxide und Propansulton.